|
|
"Molecular Signatures of Lethal and Indolent Prostate Cancer"
|
5R01CA116337-04
|
$514,171
|
$128,543
|
RUBIN, MARK
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
|
"Statistical Methods for Genetic Epidemiology"
|
5R01CA094069-08
|
$573,074
|
$49,686
|
Whittemore, Alice
|
STANFORD UNIVERSITY
|
|
|
"Strength training, Self-efficacy, and Function in Blacks with Prostate Cancer."
|
5R21CA127784-02
|
$199,964
|
$49,991
|
HURLEY, BERNARD
|
UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
|
|
|
15-Lipoxygenase-2 (ALOX15B) as a Tumor Suppressor
|
5R01CA131445-02
|
$221,524
|
$55,381
|
NIE, DAOTAI
|
SOUTHERN ILLINOIS UNIVERSITY SCH OF MED
|
|
|
18F-FACBC PET-CT for the Detection and Staging of Recurrent Prostate Carcinoma
|
5R01CA129356-03
|
$343,987
|
$85,997
|
Schuster, David
|
EMORY UNIVERSITY
|
|
|
1H MRI based nanosensors for imaging tumor oxygenation
|
1R21CA132096-01A1
|
$172,700
|
$43,175
|
Kodibagkar, Vikram
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
|
2009 Calcium Signaling Gordon Research Conference
|
1R13CA147843-01
|
$3,000
|
$990
|
FOSKETT, KEVIN
|
GORDON RESEARCH CONFERENCES
|
|
|
2009 Epigenetics Gordon Research Conference
|
1R13CA141864-01
|
$14,000
|
$2,800
|
LEE, JEANNIE
|
GORDON RESEARCH CONFERENCES
|
|
|
2009 Stem Cells and Cancer Gordon Conference
|
1R13CA139606-01
|
$6,000
|
$900
|
Jamieson, Catriona
|
GORDON RESEARCH CONFERENCES
|
|
|
3-D Transrectal Ultrasound with 2-D Arrays
|
5R01CA116379-02
|
$248,041
|
$62,010
|
YEN, JESSE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
|
5R01CA129484-02
|
$393,213
|
$24,576
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
|
A Follow-up Study for Causes of Illness in Black Women
|
2R01CA058420-16A1
|
$1,737,319
|
$868,660
|
Rosenberg, Lynn
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
A Genome-wide Association Study of Prostate Cancer in African Americans
|
1U01CA136792-01
|
$3,454,975
|
$863,744
|
HENDERSON, BRIAN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
A Longitudinal Study of the Predictors of Smoking in Women in Late Midlife
|
5R01CA122128-02
|
$593,253
|
$593,253
|
BROOK, JUDITH
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
A microfluidic platform to study the effects of chemokine gradients on prostate c
|
1R15CA133623-01A1
|
$205,407
|
$51,352
|
CHIAO, JUNG-CHIH
|
UNIVERSITY OF TEXAS ARLINGTON
|
|
|
A mouse model of stem cell deregulation and lung cancer
|
5R01CA076354-09
|
$264,921
|
$52,984
|
LOCKER, JOSEPH
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
A Neoadjuvant Trial of Anastrazole and A Novel SRC Inhibitor, AZD0530, for LABC
|
1R21CA133884-01A1
|
$294,987
|
$294,987
|
SLINGERLAND, JOYCE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
|
A New Class of Mechanistic Risk Prediction Models for Cancer Treatment Outcomes
|
5R21CA131603-02
|
$173,250
|
$43,313
|
HUANG, LI-SHAN
|
UNIVERSITY OF ROCHESTER
|
|
|
A novel function of TIMP-1
|
5R01CA089113-07
|
$269,442
|
$26,944
|
KIM, HYEONG-REH
|
WAYNE STATE UNIVERSITY
|
|
|
A Novel Inhibitor of Stat3 for Prostate Cancer Therapy
|
5R01CA104035-05
|
$280,899
|
$70,225
|
JING, NAIJIE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A Novel Synthetic Androgen Receptor Antagonist
|
5R01CA131137-02
|
$323,700
|
$80,925
|
DONG, ZHONGYUN
|
UNIVERSITY OF CINCINNATI
|
|
|
A phase II study of IPI-504 in metastatic hormone refractory prostate cancer
|
5R21CA128352-02
|
$263,979
|
$65,995
|
oh, william
|
DANA-FARBER CANCER INSTITUTE
|
|
|
A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese
|
5R01CA121023-03
|
$539,827
|
$539,827
|
LIANG, WENCHI
|
GEORGETOWN UNIVERSITY
|
|
|
A Platform for Cancer Biomarker Validation: Image Fusion Using NIR Fluorescence
|
1R01CA134493-01A1
|
$745,852
|
$186,463
|
FRANGIONI, JOHN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
A Pooled Analysis to Identify New Ovarian Cancer Risk Factors
|
1R01CA136891-01A1
|
$350,489
|
$350,489
|
PEARCE, CELESTE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
A Population Based Policy Model for Colorectal Cancer
|
5U01CA088204-09
|
$195,591
|
$48,898
|
KUNTZ, KAREN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
|
A Rigid Multivalent Chemical Platform for Targeted Diagnostics and Therapeutics
|
5F32CA132332-02
|
$53,354
|
$13,339
|
Nasr, Khaled
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
A Role of Novel Serpin Maspinin Prostate Tumor/Bone Interaction
|
5R01CA127735-02
|
$312,288
|
$78,072
|
SHENG, SHIJIE
|
WAYNE STATE UNIVERSITY
|
|
|
A Serum Marker for Aggressive Prostate Cancer
|
5R01CA121460-04
|
$439,850
|
$109,963
|
PEEHL, DONNA
|
STANFORD UNIVERSITY
|
|
|
A Sustainable Approach to Increasing Cancer Screening in Community Health Centers
|
5R01CA126596-03
|
$588,226
|
$147,057
|
EMMONS, KAREN
|
DANA-FARBER CANCER INSTITUTE
|
|
|
A trial-based MISCAN model for prostate cancer
|
3U01CA115996-04S1
|
$105,209
|
$26,302
|
DE KONING, HARRY
|
ERASMUS MEDICAL CENTER
|
|
|
A2a receptor engagement promotes T cell tolerance
|
5R01CA114227-04
|
$273,392
|
$68,348
|
POWELL, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S1
|
$114,606
|
$1,146
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S3
|
$100,000
|
$1,000
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-34
|
$7,326,647
|
$73,266
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Academic-industrial partnership for development of in vivo imaging systems and me
|
5R01CA133148-02
|
$462,824
|
$39,340
|
XU, CHRIS
|
CORNELL UNIVERSITY ITHACA
|
|
|
Accuracy of Physical Activity Measures in Cancer Studies
|
5R01CA103974-05
|
$352,092
|
$52,814
|
STERNFELD, BARBARA
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
|
Acoustic Radiation Force Imaging of Colorectal Tissues
|
5R01CA114075-05
|
$282,727
|
$35,341
|
NIGHTINGALE, KATHRYN
|
DUKE UNIVERSITY
|
|
|
Activation of the Cancer Preventive Nrf2-ARE Pathway by Seaweed
|
5R21CA133681-02
|
$156,541
|
$19,568
|
LUESCH, HENDRIK
|
UNIVERSITY OF FLORIDA
|
|
|
Adhesive Regulation During Cell Migration
|
5R01CA085862-10
|
$272,487
|
$13,624
|
HUTTENLOCHER, ANNA
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
Adiposity and Outcomes of Clinically Localized Prostate Cancer
|
1R01CA129140-01A2
|
$660,462
|
$165,116
|
Freeman, Vincent
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
|
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY
|
5R01CA116195-05
|
$245,369
|
$61,342
|
BOSLAND, MAARTEN
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
|
Adult Leukemia Research Center
|
5P01CA018029-34
|
$5,273,382
|
$210,935
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Adverse Drug Reactions in Geriatric Cancer Patients
|
5K01CA134554-02
|
$126,315
|
$126,315
|
MCKOY, JUNE
|
NORTHWESTERN UNIVERSITY
|
|
|
Age related ubiquitin defect on T-cell response to tumor
|
5R01CA107181-05
|
$217,978
|
$217,978
|
ZHANG, HUANG-GE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
Agents for Specific NMR and SQUID Imaging of Prostate Cancer
|
5R01CA123194-03
|
$454,956
|
$113,739
|
Sillerud, Laurel
|
UNIVERSITY OF NEW MEXICO
|
|
|
Alternative splicing and epithelial-mesenchymal plasticity in prostate tumors
|
1R01CA127727-01A2
|
$323,700
|
$80,925
|
Garcia-Blanco, Mariano
|
DUKE UNIVERSITY
|
|
|
American College of Radiology Imaging Network
|
5U01CA080098-11
|
$8,896,390
|
$444,820
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
AML Stem Cell Heterogeneity: Implications for Gemtuzumab Ozogomicin-based Therapy
|
1K23CA137161-01A2
|
$121,236
|
$121,236
|
Walter, Roland
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
An androgen receptor coactivator regulated in prostate
|
5R01CA112226-02
|
$351,713
|
$87,928
|
LOGAN, SUSAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Total relevant funding to Aging for this search: $145,615,459
|
